| Website | longevitybiotech.com |
| Category | BioTech |
| Employees | |
| Founded | 2010 |
| TOTAL | $350k |
| FUNDING TOTAL | $350k |
| Grant, 4/12 Thiel Foundation | $350k |
Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Founded in 2010 by President Mr. Scott Shandler, Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymes and tunable to very stable molecular structures.
